JP2002536328A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002536328A5 JP2002536328A5 JP2000596932A JP2000596932A JP2002536328A5 JP 2002536328 A5 JP2002536328 A5 JP 2002536328A5 JP 2000596932 A JP2000596932 A JP 2000596932A JP 2000596932 A JP2000596932 A JP 2000596932A JP 2002536328 A5 JP2002536328 A5 JP 2002536328A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- alkyl
- described formulation
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11910499P | 1999-02-08 | 1999-02-08 | |
| US60/119,104 | 1999-02-08 | ||
| PCT/US2000/001127 WO2000045812A1 (en) | 1999-02-08 | 2000-01-18 | Anticonvulsant derivatives useful in treating autism |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002536328A JP2002536328A (ja) | 2002-10-29 |
| JP2002536328A5 true JP2002536328A5 (https=) | 2007-02-22 |
Family
ID=22382571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000596932A Withdrawn JP2002536328A (ja) | 1999-02-08 | 2000-01-18 | 自閉症の処置に有効な抗痙攣剤誘導体 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6552000B2 (https=) |
| EP (1) | EP1152756B1 (https=) |
| JP (1) | JP2002536328A (https=) |
| AR (1) | AR029334A1 (https=) |
| AT (1) | ATE299371T1 (https=) |
| AU (1) | AU763601B2 (https=) |
| CA (1) | CA2361584C (https=) |
| DE (1) | DE60021252T2 (https=) |
| DK (1) | DK1152756T3 (https=) |
| ES (1) | ES2244411T3 (https=) |
| MX (1) | MXPA01008038A (https=) |
| PT (1) | PT1152756E (https=) |
| TR (1) | TR200103125T2 (https=) |
| WO (1) | WO2000045812A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060020037A1 (en) * | 2004-07-22 | 2006-01-26 | Allergan, Inc. | Tazarotenic acid and esters thereof for treating autism |
| US9095713B2 (en) * | 2004-12-21 | 2015-08-04 | Allison M. Foster | Methods and systems for treating autism by decreasing neural activity within the brain |
| US9327069B2 (en) * | 2004-12-21 | 2016-05-03 | Boston Scientific Neuromodulation Corporation | Methods and systems for treating a medical condition by promoting neural remodeling within the brain |
| US20070038264A1 (en) * | 2004-12-21 | 2007-02-15 | Jaax Kristen N | Methods and systems for treating autism |
| US20070034214A1 (en) * | 2005-08-12 | 2007-02-15 | Dochniak Michael J | Method to affect the development of autism spectrum disorders |
| US20090076128A1 (en) * | 2007-09-15 | 2009-03-19 | Protia Llc | Deuterium-enriched topiramate |
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
| SG11201609832XA (en) * | 2014-05-30 | 2016-12-29 | Philadelphia Children Hospital | Genetic alterations associated with autism and autistic phenotype and methods of diagnosing and treating autism |
| US11219617B2 (en) | 2014-05-30 | 2022-01-11 | The Children's Hospital Of Philadelphia | Methods of diagnosing and treating autism |
| US10206901B2 (en) | 2016-09-21 | 2019-02-19 | JC Pharma, Inc. | Method and composition for acute treatment of seizures |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
| US5753693A (en) | 1996-06-28 | 1998-05-19 | Ortho Pharmaceutical Corporation | Anticonvulsant derivatives useful in treating manic-depressive bipolar disorder |
| CA2290556A1 (en) * | 1997-05-19 | 1998-11-26 | Repligen Corporation | Method for assisting in differential diagnosis and treatment of autistic syndromes |
-
2000
- 2000-01-18 MX MXPA01008038A patent/MXPA01008038A/es active IP Right Grant
- 2000-01-18 AT AT00904390T patent/ATE299371T1/de not_active IP Right Cessation
- 2000-01-18 DK DK00904390T patent/DK1152756T3/da active
- 2000-01-18 TR TR2001/03125T patent/TR200103125T2/xx unknown
- 2000-01-18 EP EP00904390A patent/EP1152756B1/en not_active Expired - Lifetime
- 2000-01-18 JP JP2000596932A patent/JP2002536328A/ja not_active Withdrawn
- 2000-01-18 US US09/484,522 patent/US6552000B2/en not_active Expired - Fee Related
- 2000-01-18 PT PT00904390T patent/PT1152756E/pt unknown
- 2000-01-18 DE DE60021252T patent/DE60021252T2/de not_active Expired - Fee Related
- 2000-01-18 CA CA002361584A patent/CA2361584C/en not_active Expired - Fee Related
- 2000-01-18 WO PCT/US2000/001127 patent/WO2000045812A1/en not_active Ceased
- 2000-01-18 ES ES00904390T patent/ES2244411T3/es not_active Expired - Lifetime
- 2000-01-18 AU AU26156/00A patent/AU763601B2/en not_active Ceased
- 2000-02-07 AR ARP000100525A patent/AR029334A1/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004505004A5 (https=) | ||
| JP2003521471A5 (https=) | ||
| JP2002541199A5 (https=) | ||
| RU2223272C2 (ru) | Производное 2-арил-8-оксодигидропурина, способ его получения, фармацевтическая композиция и средство, содержащие его, промежуточное соединение | |
| RU2225389C2 (ru) | Производные аминометилкарбоновой кислоты и фармацевтическая композиция на их основе | |
| JP2003528808A5 (https=) | ||
| JP2003501474A5 (https=) | ||
| RU95105587A (ru) | Оптически чистые соединения пиридинилметил сульфинил-1н-бензимидазола, их соли, способы получения, фармкомпозиция, способ лечения | |
| DE60041976D1 (de) | Phenoxycarbonsäureverbindungen und zusammensetzungen zur verabreichung aktiver wirkstoffe | |
| CY1112510T1 (el) | Φαρμακευτικο παρασκευασμα υπο τη μορφη παστας το οποιο περιεχει ενα ασταθες στα οξεα δραστικο συστατικο | |
| JP2002536328A5 (https=) | ||
| ATE192153T1 (de) | Amino-imidazo (4,5-c) chinoline | |
| BR0207872A (pt) | Composto para liberar agentes ativos, composição, forma de unidade de dosagem e método de administração | |
| JP2003506416A5 (https=) | ||
| NO20100034L (no) | Fenofibrat farmasoytisk blanding som har hoy biotilgjengelighet og fremgangsmate for fremstilling av den | |
| DK0975595T3 (da) | Kokainanaloger | |
| HUP0204143A2 (en) | Tricyclic 1-benzylpyrazoles-3-carboxylic acid derivatives, preparation of the compounds, their use and pharmaceutical compositions containing them | |
| JP2002519425A5 (https=) | ||
| HUT77627A (hu) | 2,2-Diklór-alkánkarbonsavak, eljárás előállításukra és ezeket tartalmazó, inzulinrezisztencia kezelésére alkalmazható gyógyszerkészítmények | |
| SE0100569D0 (sv) | New compounds | |
| KR970705553A (ko) | 디히드로벤조푸란, 및 항염증 약물로서 유용한 관련 화합물(dihydrobenzofuran and related compounds useful as anti-inflammatory agents) | |
| PA8451701A1 (es) | Formulacion inyectable transparente de compuesto anestesico | |
| HUP0105280A2 (hu) | Benzaldehidszármazékok és gyógyászati alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények | |
| JP2002522501A5 (https=) | ||
| RU2000106042A (ru) | Способ повышения биологической доступности фексофенадина и его производных |